Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Intelligent Bio Solutions ( (INBS) ) has provided an announcement.
On November 25, 2025, Intelligent Bio Solutions Inc. issued 75,000 restricted shares of common stock to MDM Worldwide Solutions, Inc. as equity compensation for strategic communication advisory and consulting services. This issuance, exempt from registration under the Securities Act, reflects the company’s strategic move to enhance its communication capabilities without cash transactions.
The most recent analyst rating on (INBS) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on Intelligent Bio Solutions stock, see the INBS Stock Forecast page.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Underperform.
The overall stock score is heavily impacted by the company’s poor financial performance, with consistent losses and negative cash flows. Technical indicators also suggest a bearish outlook, with the stock trading below all major moving averages and showing oversold conditions. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, further weighing down the stock’s attractiveness.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. operates in the biotechnology industry, focusing on providing innovative bio-based solutions.
Average Trading Volume: 294,594
Technical Sentiment Signal: Sell
Current Market Cap: $6.34M
For a thorough assessment of INBS stock, go to TipRanks’ Stock Analysis page.